Clinical Characteristics and Outcomes of Hematologic Malignancy Patients With Positive Clostridium difficile Toxin Immunoassay Versus Polymerase Chain Reaction Test Results.

Authors

• Matthew Ziegler
• Daniel Landsburg
• David Pegues
• Kevin Alby
• Cheryl Gilmar
• Kristen Bink
• Theresa Gorman
• Amy Moore
• Brittaney Bonhomme
• Jacqueline Omorogbe
• Dana Tango
• Pam Tolomeo
• Jennifer H Han

Publication/Presentation Date

7-1-2018

Abstract

In a cohort of inpatients with hematologic malignancy and positive enzyme immunoassay (EIA) or polymerase chain reaction (PCR) Clostridium difficile tests, we found that clinical characteristics and outcomes were similar between these groups. The method of testing is unlikely to predict infection in this population, and PCR-positive results should be treated with concern.Infect Control Hosp Epidemiol 2018;863-866.

Volume

39

Issue

7

First Page

863

Last Page

866

ISSN

1559-6834

Published In/Presented At

Ziegler M, Landsburg D, Pegues D, Alby K, Gilmar C, Bink K, Gorman T, Moore A, Bonhomme B, Omorogbe J, Tango D, Tolomeo P, Han JH. Clinical Characteristics and Outcomes of Hematologic Malignancy Patients With Positive Clostridium difficile Toxin Immunoassay Versus Polymerase Chain Reaction Test Results. Infect Control Hosp Epidemiol. 2018 Jul;39(7):863-866. doi: 10.1017/ice.2018.83. Epub 2018 Apr 25. PMID: 29690940; PMCID: PMC6031467.

Disciplines

Medicine and Health Sciences | Psychiatry

PubMedID

29690940

Department(s)

Hematology-Medical Oncology Division

Document Type

Article